Loading
Latest filing published 12 May 2022 for Eupraxia Pharmaceuticals Inc., €116k.
No signal scores available.
James Besser is a declared insider of Eupraxia Pharmaceuticals Inc., with filings sourced from SEDI. In total, 5 filings cover trades dated from 20 April 2022 to 10 May 2022.
The open-market record is one-sided, with 1 purchase worth €116k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 12 May 2022, the filings show an open-market purchase worth €116k in Eupraxia Pharmaceuticals Inc. The median gap between a trade and its publication by SEDI is 13 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations